Cuban medicine with the potential to save the feet and legs of American diabetes patients is still out of reach, despite improved U.S. relations with the island. The developer of the drug is forbidden from bringing it to the U.S. for clinical trials.
From the story: "'I don’t know what’s going to happen, but I do know that it may be that American legs are being lost while Cuban legs are being saved because Washington agencies …won’t allow that medicine in,' said Dr. I. Kelman Cohen, professor emeritus in surgery at Virginia Commonwealth University."
Read the full story by Fair Warning.